Skip to Main Content

Paper Details

Genotype-targeted local therapy of glioma.
Proc Natl Acad Sci U S A
34
2018
GMX-1778, IDH, IDH mutant, IDH mutant gliomas, IDH1, IDH2 mutations, NAMPT, glioma, isocitrate, isocitrate dehydrogenase 1, isocitrate dehydrogenase 1 (IDH1) or, lower, lower-grade glioma, lower-grade gliomas, murine, mutant IDH, nicotinamide phosphoribosyltransferase, patients, tumor, tumor specimens
Author NameAffiliation
Joshua M FrancisDana-Farber Cancer Institute
Joshua M FrancisBroad Institute
Tracy T BatchelorStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Tracy T BatchelorStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Priscilla K BrastianosStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Anthony J IafrateMassachusetts General Hospital
Andrew S ChiLaura and Isaac Perlmutter Cancer Center, New York University School of Medicine and New York University Langone Health
Jochen K LennerzMassachusetts General Hospital
Matthew MeyersonDana-Farber Cancer Institute
Matthew MeyersonBroad Institute
Matthew MeyersonDana-Farber Cancer Institute
Matthew MeyersonBroad Institute
Robert LangerMassachusetts Institute of Technology
Robert LangerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • 1 - 14

Datasets

Release 1.2